Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)

Explore clinical trials studying Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder) trial results

Recruiting

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

NCT06372821

Conditions: Alzheimer Disease, Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder), Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder), +9 more
Locations: Washington University in St. Louis St Louis, Missouri, United States

University College London Hospitals NHS Foundation Trust London, United Kingdom

View Trial Details

Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder)

Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder) trial results

A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK

Related conditions